AVACEN Medical Receives CE (Conformité Européenne) Mark for Increasing Microcirculation and Treating Widespread Fibromyalgia Pain

SAN DIEGO, Aug. 4, 2017 -- (Healthcare Sales & Marketing Network) -- AVACEN Medical (AVACEN) announced its AVACEN 100, Class II, OTC medical device has received the CE (Conformité Européenne) Mark approval to treat widespread pain associated... Devices, Regulatory AVACEN Medical, AVACEN 100, fibromyalgia syndrome
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news